CST Annual Research Forum 2020
Calling all researchers, health professionals and consumer representatives with an interest in cancer symptom management and supportive care. Let's join forces to spark fresh research ideas and address clinical gaps.
Join us at the CST Annual Research Forum. The 2020 theme is Vision 2030: Cancer Symptom Trials.
The forum offers the perfect opportunity to collaborate on ideas and insights in cancer symptom management and supportive care with researchers and interdisciplinary clinicians.
You can expand your research and interdisciplinary networks and build the capacity of your ideas through clinical study design, execution, analysis and dissemination.
By the end, we wish to hold a portfolio of trial ideas to address clinical gaps.
You will hear from accomplished guest speakers and discussion panels. There will also be updates from the chairs of four of our research symptom node subcommittees: appetite and cachexia, pain, fatigue, and nausea.
Join us in our endeavours to manage the symptoms of cancer and improve supportive care.
Do you have a new study idea?
Present your study idea at the CST Annual Research Forum 2020. This is a fantastic opportunity to share your idea and get expert feedback from clinicians, researchers and consumers.
Past presentations have led to the development of ideas from concept to clinical trial implementation. The IMPACCT Trials Coordination Centre can support your study through research assistance, writing support and data coordination.
Professor Dorothy Keefe
Professor Dorothy Keefe is the CEO of Cancer Australia. Prior to this, Professor Keefe worked as a medical oncologist at the Royal Adelaide Hospital, and as Professor of Cancer Medicine at the University of Adelaide where she remains an Honorary Clinical Professor. She has an ongoing long-term research interest in supportive care in cancer, particularly in gastrointestinal toxicity of cancer treatment. She ran a laboratory studying mechanisms and interventions for over 20 years. She is a past-President of the Multinational Association of Supportive Care in Cancer (MASCC).
Professor Keefe has led cancer services at hospital, local health network and state levels, and spent four years as a clinical lead of health reform in South Australia. She has a masters degree in medical leadership and has a strong interest in advocacy and career development and mentoring. In 2013, she was awarded a Public Service Medal for her service to public health, medical research and oncology.
Professor Vickie Baracos
Our keynote speaker, Professor Vickie Baracos is Alberta Cancer Foundation Chair in Palliative Care Medicine in the Department of Oncology, University of Alberta. Her long-term focus has been the pathophysiology of skeletal muscle atrophy in an effort that encompasses fundamental and translational research, a clinical agenda and an international network of strategic collaboration.
Cancer cachexia, a debilitating condition characterised by profound atrophy of skeletal muscle is her main focus. Some key publications include Baracos VE et al. Cancer-associate cachexia. Nat Rev Dis Primers. 2018; 4:17105; Martin L et al. Diagnostic criteria for the classification of cancer-associated weight loss. J Clin Oncol. 2015;33(1):90-9. Fearon K et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12(5):489-95.
Professor Baracos developed the use of clinical computed tomography to detect and precisely measure muscle loss, which is an integral part of cachexia. Muscle loss is strongly associated with severe chemotherapy toxicity, complications of surgery and mortality in patients with different cancers.
Associate Professor Richard De Abreu Lourenco
Richard is an Associate Professor with CHERE. He is an experienced health economist who has a keen interest in applied economic evaluations, patient preferences and quality of life, and the economics of speciality health areas.
Richard is currently the Program Lead for the Cancer Australia Cancer Research Economics Support Team, and the Senior Evaluator for CHERE’s Pharmaceutical Benefits Advisory Committee (PBAC) evaluation group. He is an investigator on a number of cancer clinical studies and studies investigating preferences for health care decision making.
CST Annual Research Forum 2020 flyer (PDF, 398KB).
CST ANNUAL RESEARCH FORUM 2020 PROGRAM (pdf, 708kb)
CST ANNUAL RESEARCH FORUM 2020 PROGRAM AND SPEAKERS (pdf, 709kb)